Alagille Syndrome 1; Algs1
Description
Alagille syndrome is an autosomal dominant disorder that traditionally has been defined by a paucity of intrahepatic bile ducts, in association with 5 main clinical abnormalities: cholestasis, cardiac disease, skeletal abnormalities, ocular abnormalities, and a characteristic facial phenotype (Li et al., 1997). Cholestasis is a direct consequence of the paucity of bile ducts. About 39% of patients also have renal involvement, mainly renal dysplasia (Kamath et al., 2012).Turnpenny and Ellard (2012) reviewed the clinical features, diagnosis, pathogenesis, and genetics of Alagille syndrome.
Clinical Features
Top most frequent phenotypes and symptoms related to Alagille Syndrome 1; Algs1
- Intellectual disability
- Global developmental delay
- Short stature
- Hearing impairment
- Growth delay
- Hypertelorism
- Neoplasm
- Failure to thrive
- Micrognathia
- Strabismus
And another 128 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Based on the latest data available ALAGILLE SYNDROME 1; ALGS1 have a estimated birth prevalence of 0.8 per 100k worldwide.— No data available about the known clinical features onset.
Alternative names
Alagille Syndrome 1; Algs1 Is also known as algs, alagille-watson syndrome, alagille syndrome, hepatic ductular hypoplasia, syndromatic, arteriohepatic dysplasia, aws, cholestasis with peripheral pulmonary stenosis, ahd.
Researches and researchers
Doctors, researchs, and experts related to Alagille Syndrome 1; Algs1 extracted from public data.
Alagille Syndrome 1; Algs1 Experts map
Current Researchs and researchers
-
Investigator of research projectCAMBRIDGE — Dr Fotios SAMPAZIOTIS
-
Institution/s:
— University of Cambridge -
Research area/topic::
In vitro modelling of biliary development and diseases
-
Institution/s:
Alagille Syndrome 1; Algs1 Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
![]() By Baylor Miraca Genetics Laboratories (United States).
RGS9, RHO, GRK1, RLBP1, RNASEL, BCS1L, RP1, RP2, RP9, RPE65, RPGR, RPL35A, MRPL3, RPS14, RS1, SAG, SARDH, SCO2, SCP2, SDHB , (...)
View the complete list with 612 more genes
Specificity
1 %
Genes
100 % |
![]() By Baylor Miraca Genetics Laboratories (United States).
JAG1
Specificity
100 %
Genes
100 % |
![]() By Baylor Miraca Genetics Laboratories (United States).
JAG1
Specificity
100 %
Genes
100 % |
![]() By Baylor Miraca Genetics Laboratories (United States).
JAG1
Specificity
100 %
Genes
100 % |
![]() By Baylor Miraca Genetics Laboratories (United States).
JAG1
Specificity
100 %
Genes
100 % |
![]() By Baylor Miraca Genetics Laboratories (United States).
RIT1, BRAF, SMC1A, SOS1, SOS2, CDKL5, SYNGAP1, TSC1, TSC2, HDAC8, NSD1, CBL, SHOC2, CHD7, COL1A2, SMC3, NIPBL, FGFR2, FGFR3, HRAS , (...)
View the complete list with 9 more genes
Specificity
4 %
Genes
100 % |
![]() By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University (United States).
SLC25A13, ATP8B1, AKR1D1, ABCB4, JAG1
Specificity
20 %
Genes
100 % |
![]() By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States).
JAG1
Specificity
100 %
Genes
100 % |
You can get up to 113 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
OMIM ORPHANET Rare Disease Symptoms CheckerIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2 BOMBAY PHENOTYPE ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3; IIAE3 PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3; MC3DN3 NEWFOUNDLAND ROD-CONE DYSTROPHY; NFRCD AORTIC VALVE DISEASE 2; AOVD2